{ "items" : [
    { "id" : "http://dbpedia.org/resource/Sevelamer"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Sevelamer (rINN) (/sɛˈvɛləmər/ or /sɛˈvɛləmɪər/) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate)." ] ,
        "http://xmlns.com/foaf/0.1/depiction" : [ "http://commons.wikimedia.org/wiki/Special:FilePath/Sevelamer.png" ] ,
        "http://dbpedia.org/ontology/atcPrefix" : [ "V03" ] ,
        "http://dbpedia.org/ontology/atcSuffix" : [ "AE02" ] ,
        "http://dbpedia.org/ontology/casNumber" : [ "52757-95-6" ] ,
        "http://dbpedia.org/ontology/drugbank" : [ "DB00658" ] ,
        "http://dbpedia.org/ontology/fdaUniiCode" : [ "941N5DUU5C" ] ,
        "http://dbpedia.org/ontology/iupacName" : [ "co-N,N'-diallyl-1,3-diamino-2-hydroxypropane)",
          "poly(allylamine-" ] ,
        "http://dbpedia.org/ontology/pubchem" : [ "3085017" ] ,
        "http://dbpedia.org/ontology/thumbnail" : [ "http://commons.wikimedia.org/wiki/Special:FilePath/Sevelamer.png?width=300"] } } }
